Long-Term Follow-Up of Hospitalized Dengue and Safety in Thai Children Who Were Included in an Efficacy Study of a Tetravalent Dengue Vaccine
Latest Information Update: 14 Apr 2021
At a glance
- Drugs CYD TDV (Primary) ; Rabies vaccine
- Indications Dengue
- Focus Therapeutic Use
- Sponsors Sanofi
- 04 Apr 2021 Results of post-hoc analysis assessing hospitalized and severe VCD cases over the entire six-year follow-up of (two Phase III trials (CYD14 [NCT01373281] and CYD15 [NCT01374516]) and the Phase IIb trial (CYD23/CYD57 [NCT00842530/NCT01983553]) published in the Clinical Infectious Diseases
- 13 Jun 2018 Results of post-hoc analysis assessing effect of dengue serostatus on vaccine safety and efficacy by using data from four trials including this trial published in the New England Journal of Medicine.
- 27 Sep 2016 Status changed from active, no longer recruiting to completed.